Form 4: Intellia Therapeutics Executive Sells Shares to Cover Tax Obligations

Michael P. Dube, VP and Chief Accounting Officer of Intellia Therapeutics, sold 2,012 shares of common stock to cover tax obligations arising from the vesting of RSUs.

Summary

• On October 2, 2024, Michael P. Dube, VP and Chief Accounting Officer of Intellia Therapeutics, sold 2,012 shares of the company's common stock.
• The sale was executed to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs) on October 1, 2024.
• The shares were sold at a weighted average price of $19.01, with individual transactions ranging from $18.95 to $19.01.
• Following the transaction, Dube still beneficially owns 47,012 shares of Intellia Therapeutics common stock.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sell-to-cover) for tax purposes, so it's neutral in sentiment.

Industry Context

Sales of shares to cover tax obligations upon vesting of RSUs are a common practice among corporate executives and are generally not indicative of the company's financial health or future prospects.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant effect on the company's operations or financial performance.

Key Dates